fluorodopa f 18 has been researched along with Local Neoplasm Recurrence in 23 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (8.70) | 29.6817 |
| 2010's | 20 (86.96) | 24.3611 |
| 2020's | 1 (4.35) | 2.80 |
| Authors | Studies |
|---|---|
| Breen, WG; Brinkmann, DH; Brown, PD; Giri, S; Hunt, CH; Jacobson, SB; Jones, JE; Kizilbash, SH; Laack, NN; Mahajan, A; Pafundi, DH; Routman, DM; Ruff, MW; Uhm, JH; Youland, RS | 1 |
| Brinkmann, DH; Giannini, C; Hunt, CH; Kemp, BJ; Laack, NN; Lowe, VJ; Morris, JM; Pafundi, DH; Parney, IF; Youland, RS | 1 |
| Gao, L; Liang, F; Tao, L; Weng, J; Xu, W; Yu, J; Zhang, J; Zheng, J | 1 |
| Bellu, L; Bertin, D; Caccese, M; Cuppari, L; Evangelista, L; Lombardi, G; Reccia, P; Zagonel, V | 1 |
| Balogova, S; Kaliska, L; Kunikowska, J; Montravers, F; Slavikova, K; Talbot, JN; Treglia, G; Vereb, M | 1 |
| Benard, F; Chan, EK; Cheung, A; Hsu, F; Kosztyla, R; Ma, R; Moiseenko, V; Nichol, A; Wilson, D; Zhang, S | 1 |
| Bal, C; Ballal, S; Gupta, DK; Karunanithi, S; Khangembam, BC; Kumar, A; Kumar, R; Sharma, P | 1 |
| Afshar-Oromieh, A; Combs, SE; Debus, J; Giesel, FL; Haberkorn, U; Kratochwil, C; Leotta, K; Rieken, S | 1 |
| Benz, MR; Buck, AK; Chen, W; Cloughesy, T; Czernin, J; Herrmann, K; Lai, A; Phelps, ME; Pomykala, KL | 1 |
| Chen, W; Cloughesy, TF; Czernin, J; Elashoff, D; Ellingson, BM; Geist, C; Grogan, T; Phelps, ME; Pope, WB; Schwarzenberg, J; Silverman, DH | 1 |
| Chen, W; De Salles, AA; Lizarraga, KJ | 1 |
| Chen, W; Cloughesy, TF; Czernin, J; Ellingson, BM; Harris, RJ; Karavaeva, E; Lai, A; Leu, K; Liau, LM; Nghiemphu, PL; Pope, WB; Shabihkhani, M; Yong, WH | 1 |
| Chen, W; Cloughesy, T; Czernin, J; Freitas, B; Ledezma, CJ; Pope, W; Sai, V | 1 |
| Ambrosini, V; Fanti, S; Marzola, MC; Rubello, D | 1 |
| Cavet, M; Dousset, B; Faraggi, M; Hignette, C; Modis, C; Richard, B; Tenenbaum, F | 1 |
| Al-Nahhas, A; Ambrosini, V; Fanti, S; Ferdeghini, M; Gross, MD; Marzola, MC; Massaro, A; Pelizzo, MR; Rubello, D; Toniato, A | 1 |
| Chen, X; Cleary, S; Dawson, LF; Eisenhofer, G; Kiesewetter, DO; Kvetnansky, R; Lai, EW; Martiniova, L; Pacak, K; Phillips, JK; Powers, JF; Seidel, J; Thomasson, D | 1 |
| Cloughesy, T; Czernin, J; Fueger, B; Lai, A; Nghiemphu, P; Phelps, ME; Satyamurthy, N; Wagle, N; Walter, F; Walter, MA | 1 |
| Calabria, F; Chiaravalloti, A; Di Pietro, B; Grasso, C; Schillaci, O | 1 |
| Cocciolillo, F; de Waure, C; Di Nardo, F; Giordano, A; Poscia, A; Rufini, V; Treglia, G | 1 |
| Goichot, B; Hubele, F; Imperiale, A; Rust, E; Taieb, D; Taquet, MC; Veillon, F | 1 |
| Ambrosini, V; Castaldi, P; Cremonini, N; Fanti, S; Filice, A; Giordano, A; Perotti, G; Rufini, V; Treglia, G; Versari, A; Villani, MF | 1 |
| Beuthien-Baumann, B; Bredow, J; Kotzerke, J; Strumpf, A; Zessin, J | 1 |
6 review(s) available for fluorodopa f 18 and Local Neoplasm Recurrence
| Article | Year |
|---|---|
Accuracy of
Topics: Brain Neoplasms; Diagnosis, Differential; Dihydroxyphenylalanine; Humans; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Prospective Studies; Radiation Injuries; Retrospective Studies; Tyrosine | 2018 |
Comparison Between 18F-Dopa and 18F-Fet PET/CT in Patients with Suspicious Recurrent High Grade Glioma: A Literature Review and Our Experience.
Topics: Brain Neoplasms; Dihydroxyphenylalanine; Glioma; Humans; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Tyrosine | 2019 |
What is currently the best radiopharmaceutical for the hybrid PET/CT detection of recurrent medullary thyroid carcinoma?
Topics: Amines; Blood Glucose; Bone and Bones; Carcinoma, Neuroendocrine; Dihydroxyphenylalanine; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Multimodal Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiation Dosage; Radiopharmaceuticals; Receptors, Somatostatin; Thyroid Neoplasms; Tomography, X-Ray Computed | 2013 |
Molecular imaging of brain tumors with 18F-DOPA PET and PET/CT.
Topics: Brain Neoplasms; Dihydroxyphenylalanine; Fluorine Radioisotopes; Humans; Magnetic Resonance Imaging; Multimodal Imaging; Neoplasm Metastasis; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Sensitivity and Specificity; Tomography, X-Ray Computed | 2012 |
Detection rate of recurrent medullary thyroid carcinoma using fluorine-18 dihydroxyphenylalanine positron emission tomography: a meta-analysis.
Topics: Carcinoma, Neuroendocrine; Dihydroxyphenylalanine; Humans; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prevalence; Radiopharmaceuticals; Reproducibility of Results; Risk Factors; Sensitivity and Specificity; Thyroid Neoplasms | 2012 |
Comparison of different positron emission tomography tracers in patients with recurrent medullary thyroid carcinoma: our experience and a review of the literature.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Neuroendocrine; Dihydroxyphenylalanine; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Thyroid Neoplasms; Tomography, X-Ray Computed | 2013 |
2 trial(s) available for fluorodopa f 18 and Local Neoplasm Recurrence
| Article | Year |
|---|---|
Initial results of a phase II trial of
Topics: Adult; Brain Neoplasms; Dihydroxyphenylalanine; Glioma; Humans; Magnetic Resonance Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Re-Irradiation | 2022 |
Prospective trial evaluating the sensitivity and specificity of 3,4-dihydroxy-6-[18F]-fluoro-L-phenylalanine (18F-DOPA) PET and MRI in patients with recurrent gliomas.
Topics: Adolescent; Adult; Brain; Brain Neoplasms; Contrast Media; Dihydroxyphenylalanine; Female; Glioma; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Grading; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Salvage Therapy; Sensitivity and Specificity; Young Adult | 2018 |
15 other study(ies) available for fluorodopa f 18 and Local Neoplasm Recurrence
| Article | Year |
|---|---|
High-grade glioma radiation therapy target volumes and patterns of failure obtained from magnetic resonance imaging and 18F-FDOPA positron emission tomography delineations from multiple observers.
Topics: Adult; Aged; Astrocytoma; Brain Neoplasms; Contrast Media; Dihydroxyphenylalanine; Female; Fluorine Radioisotopes; Gadolinium; Glioblastoma; Glioma; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Observer Variation; Oligodendroglioma; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Sensitivity and Specificity; Tumor Burden; Young Adult | 2013 |
Can (18)F-FDOPA PET/CT predict survival in patients with suspected recurrent glioma? A prospective study.
Topics: Adolescent; Adult; Brain Neoplasms; Child; Dihydroxyphenylalanine; Female; Glioma; Humans; India; Male; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prevalence; Prospective Studies; Radiopharmaceuticals; Reproducibility of Results; Risk Assessment; Sensitivity and Specificity; Survival Rate; Tomography, X-Ray Computed; Young Adult | 2014 |
Intra-individual comparison of ¹⁸F-FET and ¹⁸F-DOPA in PET imaging of recurrent brain tumors.
Topics: Astrocytoma; Brain Neoplasms; Dihydroxyphenylalanine; Glioblastoma; Humans; Neoplasm Recurrence, Local; Positron-Emission Tomography; Tyrosine | 2014 |
Comparison of visual and semiquantitative analysis of 18F-FDOPA-PET/CT for recurrence detection in glioblastoma patients.
Topics: Adult; Aged; Aged, 80 and over; Dihydroxyphenylalanine; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Glioblastoma; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Survival Rate; Tomography, X-Ray Computed; Young Adult | 2014 |
Treatment response evaluation using 18F-FDOPA PET in patients with recurrent malignant glioma on bevacizumab therapy.
Topics: Adult; Aged; Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Brain Neoplasms; Dihydroxyphenylalanine; Female; Glioma; Humans; Male; Middle Aged; Neoplasm Grading; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Treatment Outcome; Tumor Burden | 2014 |
¹⁸F-fluorodopa positron-emission tomography: an emerging imaging modality for patients with brain metastases.
Topics: Biopsy; Brain Neoplasms; Dihydroxyphenylalanine; Disease Progression; Humans; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiation Injuries | 2014 |
Relationship Between [18F]FDOPA PET Uptake, Apparent Diffusion Coefficient (ADC), and Proliferation Rate in Recurrent Malignant Gliomas.
Topics: Adult; Aged; Brain Neoplasms; Cell Proliferation; Contrast Media; Diffusion; Dihydroxyphenylalanine; Female; Glioma; Humans; Image Processing, Computer-Assisted; Immunohistochemistry; Inflammation; Ki-67 Antigen; Magnetic Resonance Imaging; Male; Middle Aged; Mitosis; Mitotic Index; Neoplasm Recurrence, Local; Positron-Emission Tomography; Retrospective Studies; Young Adult | 2015 |
18F-FDOPA PET/MRI fusion in patients with primary/recurrent gliomas: initial experience.
Topics: Adult; Aged; Brain Neoplasms; Dihydroxyphenylalanine; Female; Glioma; Humans; Image Enhancement; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Recurrence, Local; Pilot Projects; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique | 2009 |
(68)Ga-somatostatin analogues PET and (18)F-DOPA PET in medullary thyroid carcinoma.
Topics: Carcinoma, Medullary; Dihydroxyphenylalanine; Humans; Neoplasm Recurrence, Local; Organometallic Compounds; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Somatostatin; Thyroid Gland; Thyroid Neoplasms | 2010 |
[Recurrent carcinoid tumor and 18F-DOPA PET].
Topics: Biomarkers, Tumor; Carcinoid Tumor; Colonic Neoplasms; Dihydroxyphenylalanine; Fluorine Radioisotopes; Humans; Liver Neoplasms; Male; Middle Aged; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Peritoneal Neoplasms; Positron-Emission Tomography; Predictive Value of Tests; Sensitivity and Specificity | 2010 |
Dual PET/CT with (18)F-DOPA and (18)F-FDG in metastatic medullary thyroid carcinoma and rapidly increasing calcitonin levels: Comparison with conventional imaging.
Topics: Adult; Aged; Biomarkers, Tumor; Calcitonin; Carcinoma, Medullary; Chi-Square Distribution; Dihydroxyphenylalanine; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiography; Radiopharmaceuticals; Sensitivity and Specificity; Statistics, Nonparametric; Thyroid Neoplasms; Thyroidectomy | 2010 |
Usefulness of [18F]-DA and [18F]-DOPA for PET imaging in a mouse model of pheochromocytoma.
Topics: Adrenal Gland Neoplasms; Animals; Contrast Media; Dihydroxyphenylalanine; Dopamine; Female; Liver Neoplasms; Lung Neoplasms; Magnetic Resonance Imaging; Mice; Neoplasm Recurrence, Local; Neoplasms, Experimental; Norepinephrine Plasma Membrane Transport Proteins; Ovarian Neoplasms; Pheochromocytoma; Positron-Emission Tomography; Sensitivity and Specificity; Tomography, X-Ray Computed; Vesicular Monoamine Transport Proteins | 2012 |
Impact of 3,4-dihydroxy-6-18F-fluoro-L-phenylalanine PET/CT on managing patients with brain tumors: the referring physician's perspective.
Topics: Adult; Aged; Aged, 80 and over; Astrocytoma; Brain Neoplasms; Dihydroxyphenylalanine; Female; Follow-Up Studies; Humans; Image Processing, Computer-Assisted; Logistic Models; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Oligodendroglioma; Patient Care Management; Physicians; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Surveys and Questionnaires; Tomography, X-Ray Computed; Young Adult | 2012 |
Head-to-head comparison between SRS, (18)F-FDG and (18)F-FDOPA PET/CT in a patient with recurrent SDHC-related jugular paraganglioma.
Topics: Dihydroxyphenylalanine; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Membrane Proteins; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Paraganglioma; Positron-Emission Tomography; Tomography, X-Ray Computed | 2012 |
Diagnostic impact of PET with 18F-FDG, 18F-DOPA and 3-O-methyl-6-[18F]fluoro-DOPA in recurrent or metastatic medullary thyroid carcinoma.
Topics: Adult; Aged; Carcinoma, Medullary; Dihydroxyphenylalanine; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Thyroid Neoplasms | 2007 |